
N-Desmethyl imatinib
CAS No. 404844-02-6
N-Desmethyl imatinib( Norimatinib | Imatinib metabolite N-Desmethyl imatinib )
Catalog No. M26257 CAS No. 404844-02-6
N-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 160 | In Stock |
![]() ![]() |
10MG | 302 | In Stock |
![]() ![]() |
25MG | 512 | In Stock |
![]() ![]() |
50MG | 736 | In Stock |
![]() ![]() |
100MG | 1017 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameN-Desmethyl imatinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
DescriptionN-Desmethyl imatinib is a metabolite of Imatinib, which is a multi-target inhibitor of c-Kit, v-Abl, and PDGFR.
-
In Vitro——
-
In Vivo——
-
SynonymsNorimatinib | Imatinib metabolite N-Desmethyl imatinib
-
PathwayAngiogenesis
-
TargetBcr-Abl
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404844-02-6
-
Formula Weight479.588
-
Molecular FormulaC28H29N7O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (208.52 mM)
-
SMILESCc1ccc(NC(=O)c2ccc(CN3CCNCC3)cc2)cc1Nc1nccc(n1)-c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim B, et al. Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Sci Rep. 2019;9(1):7741. Published 2019 May 23.
molnova catalog



related products
-
Dasatinib
A potent, orally bioavailable, dual Src/Abl kinase inhibitor.
-
Imatinib impurities3
Imatinib impurities3 is a protein kinases inhibitor with IC50 values of 6.95uM, 0.245uM, 0.139uM for ABL1 wt, KIT wt, PDGFRR wt, respectively.
-
CHMFL-ABL-121
CHMFL-ABL-121 is a highly potent inhibitor of type II ABL kinase.